title: Comparative genomic hybridization: comparison between esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-incidence area for both cancers in Henan, northern China.
abstract: Esophageal squamous cell carcinoma (SCC) remains the leading cause of cancer related deaths in Linzhou (formerly Linxian), the highest incidence area for esophageal cancer (EC) in Henan, northern China. In China, gastric cardia adenocarcinoma (GCA) shares very similar geographic distribution with SCC, suggesting the possibility of similar risk factors involved in SCC and GCA carcinogenesis in these areas. However, the underlying genetic alterations for esophageal and gastric cardia carcinogenesis, especially for the molecular difference between SCC and GCA, are largely unknown. The present study was thus undertaken to determine the difference in chromosomal aberrations in SCC (n = 37) and GCA (n = 31) using the comparative genomic hybridization method (CGH). All the patients were from Linzhou, Henan, a high-risk geographic region for both SCC and GCA. CGH results showed that chromosomal aberrations with different degrees were identified both in SCC and GCA. In SCC, chromosomal profile of DNA copy number was characterized by most frequently detected gains at 8q (29/37, 78%), 3q (24/37, 65%) and 5p (19/37, 51%); and frequently detected losses at 3p (21/37, 57%), 8p and 9q (14/37, 38%). In GCA, the frequently detected gains were identified at 20q (13/31, 42%), 6q (12/31, 39%) and 8q (11/31, 35%); the DNA copy number losses in GCA occurred frequently at 17p (17/31, 55%), 19p (15/31, 48%) and 1p (14/31, 45%). Statistically, there were evident differences between SCC and GCA in DNA copy number gains at 8q, 3q, 5p and 20q (P < 0.05) and in losses at 3p, 8p, 5q, 17p and 18q (P < 0.05). Gains at 8q were frequently observed in both SCC and GCA. Gains at 3q and 8p were frequently observed in TNM stage III of both SCC and GCA. The present CGH results provide candidate regions that may contain specific related genes involved in SCC and GCA in the Linzhou population. Gains at 8q, 3q and 5p and losses at 3p, 8p and 9q were specifically implicated in SCC; gains at 20q, 6q and 8q and losses at 17p, 19p and 1p were specifically implicated in GCA; gains at 8q were implicated in both SCC and GCA.
authors.affiliation: Henan Key Laboratory for Esophageal Cancer and Laboratory for Cancer Research, Cancer Research Center of Xinxiang Medical College, Xinxiang, Henan Province, China. ldwang@zzu.edu.cn
authors.forename: L D
authors.initials: LD
authors.lastname: Wang
authors.forename: Y R
authors.initials: YR
authors.lastname: Qin
authors.forename: Z M
authors.initials: ZM
authors.lastname: Fan
authors.forename: D
authors.initials: D
authors.lastname: Kwong
authors.forename: X Y
authors.initials: XY
authors.lastname: Guan
authors.forename: G S-W
authors.initials: GS
authors.lastname: Tsao
authors.forename: J
authors.initials: J
authors.lastname: Sham
authors.forename: J L
authors.initials: JL
authors.lastname: Li
authors.forename: X S
authors.initials: XS
authors.lastname: Feng
mesh_terms: D000230:Adenocarcinoma / Q000453:epidemiology / Q000235:genetics*; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D002299:Cardia; D002681:China / Q000453:epidemiology; D002869:Chromosome Aberrations; D004938:Esophageal Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D018628:Gene Dosage / Q000235:genetics; D020869:Gene Expression Profiling; D006801:Humans; D015994:Incidence; D009367:Neoplasm Staging